EUVIMEDEUVIMED entdecken
Crossref

SARS‐CoV‐2 infection alters the gut microbiome in diabetes patients: A cross‐sectional study from Bangladesh

Adnan Mannan iD, M Nazmul Hoque iD, Sajjad Hossain Noyon iD, H M Hamidullah Mehedi iD, Md Javed Foysal iD, Asma Salauddin iD, S M Rafiqul Islam iD, Farjana Sharmen iD, Afroza Akter Tanni iD, Amam Zonaed Siddiki iD, Alfred Tay, Md Moradul Siddique und 3 weitere

Journal of Medical Virology · 2023

DOI: 10.1002/jmv.28691 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Adnan Mannan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetic Engineering and Biotechnology, University of Chittagong, Chattogram, Bangladesh. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Diabetes Mellitus, Type 2, COVID-19. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: University of Chittagong.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Populations of different South Asian nations including Bangladesh reportedly have a high risk of developing diabetes in recent years. This study aimed to investigate the differences in the gut microbiome of COVID‐19‐positive participants with or without type 2 diabetes mellitus (T2DM) compared with healthy control subjects. Microbiome data of 30 participants with T2DM were compared with 22 age‐, sex‐, and body mass index (BMI)‐matched individuals. Clinical features were recorded while fecal samples were collected aseptically from the participants. Amplicon‐based (16S rRNA) metagenome analyses were employed to explore the dysbiosis of gut microbiota and its correlation with genomic and functional features in COVID‐19 patients with or without T2DM. Comparing the detected bacterial genera across the sample groups, 98 unique genera were identified, of which 9 genera had unique association with COVID‐19 T2DM patients. Among different bacterial groups, Shigella (25%), Bacteroides (23.45%), and Megamonas (15.90%) had higher mean relative abundances in COVID‐19 patients with T2DM. An elevated gut microbiota dysbiosis in T2DM patients with COVID‐19 was observed while some metabolic functional changes correlated with bidirectional microbiome dysbiosis between diabetes and non‐diabetes humans gut were also found. These results further highlight the possible association of COVID‐19 infection that might be linked with alteration of gut microbiome among T2DM patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeDiabetes Mellitus, Type 2COVID-19HumansCross-Sectional StudiesRNA, Ribosomal, 16SDysbiosisBangladeshSARS-CoV-2Bacteria

Stichwörter der Autor:innen

BangladeshCOVID-19diabetesgut microbiomemetagenome

Substanzen

RNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of Genetic Engineering and Biotechnology, University of Chittagong, Chattogram, Bangladesh.
  • Department of Endocrinology, Chittagong Medical College, Chattogram, Bangladesh.
  • Next Generation Sequencing, Research and Innovation laboratory Chittagong (NRICh), Biotechnology Research and Innovation Centre (BRIC), Department of Genetic Engineering and Biotechnology, University of Chittagong, Chat…
  • Department of Gynecology, Obstetrics and Reproductive Health, Bangabandhu Sheikh Mujibur Rahman Agricultural University, Gazipur, Bangladesh.
  • Department of Medicine, 250 Bedded General Hospital, Chattogram, Bangladesh.
  • School of Molecular and Life Sciences, Curtin University, Bentley, WA, Australia.

ORCID-Profile: Adnan Mannan, M Nazmul Hoque, Sajjad Hossain Noyon, H M Hamidullah Mehedi, Md Javed Foysal, Asma Salauddin, S M Rafiqul Islam, Farjana Sharmen, Afroza Akter Tanni, Amam Zonaed Siddiki, Farhana Akter

Förderung

  • University of Chittagong

Zitieren

APA

Mannan, A., Hoque, M. N., Noyon, S. H., Mehedi, H. M. H., Foysal, M. J., Salauddin, A., Islam, S. M. R., Sharmen, F., Tanni, A. A., Siddiki, A. Z., Tay, A., Siddique, M. M., Rahman, M. S., Galib, S. M., & Akter, F. (2023). SARS‐CoV‐2 infection alters the gut microbiome in diabetes patients: A cross‐sectional study from Bangladesh. Journal of Medical Virology. https://doi.org/10.1002/jmv.28691

Vancouver

Mannan A, Hoque MN, Noyon SH, Mehedi HMH, Foysal MJ, Salauddin A, et al. SARS‐CoV‐2 infection alters the gut microbiome in diabetes patients: A cross‐sectional study from Bangladesh. Journal of Medical Virology. 2023. doi:10.1002/jmv.28691

BibTeX
@article{Mannan2023,
  author = {Mannan, Adnan and Hoque, M Nazmul and Noyon, Sajjad Hossain and Mehedi, H M Hamidullah and Foysal, Md Javed and Salauddin, Asma and Islam, S M Rafiqul and Sharmen, Farjana and Tanni, Afroza Akter and Siddiki, Amam Zonaed and Tay, Alfred and Siddique, Md Moradul and Rahman, M Shaminur and Galib, Syed Md and Akter, Farhana},
  title = {SARS‐CoV‐2 infection alters the gut microbiome in diabetes patients: A cross‐sectional study from Bangladesh},
  journal = {Journal of Medical Virology},
  year = {2023},
  doi = {10.1002/jmv.28691}
}
Kostenlos starten →